Respiratory viruses other than influenza virus: Impact and therapeutic advances

Clinical Microbiology Reviews

Volumn 21, Issue 2, 2008, Pages 274-290

  Nichols, W Garrett ^a   Peck Campbell, Angela J ^b,c,d   Boeckh, Michael ^b,d  

^a GLAXOSMITHKLINE   (United Kingdom)

^b Fred Hutchinson Cancer Research Center   (United States)

^c SEATTLE CHILDREN S RESEARCH INSTITUTE   (United States)

^d UNIVERSITY OF WASHINGTON   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

5 [5 [2,6 DICHLORO 4 (4,5 DIHYDRO 2 OXAZOLYL)PHENOXY]PENTYL] 3 METHYLISOXAZOLE; 9 (3 HYDROXY 2 PHOSPHONOMETHOXYPROPYL)ADENINE; A 60444; ALN RSV01; ALPHA2B INTERFERON; ANTIVIRUS AGENT; BENZODIAZEPINE; BTA 9881; CIDOFOVIR; CORTICOSTEROID; DISOXARIL; ECHINACEA EXTRACT; INTERFERON; LOPINAVIR PLUS RITONAVIR; MOTAVIZUMAB; NELFINAVIR; NUCLEOSIDE ANALOG; PALIVIZUMAB; PLECONARIL; PROTEINASE INHIBITOR; RECOMBINANT INTERCELLULAR ADHESION MOLECULE 1; RESPIRATORY SYNCYTIAL VIRUS ANTIBODY; RIBAVIRIN; RSV 604; RUPINTRIVIR; SMALL INTERFERING RNA; TMC 353121; UNCLASSIFIED DRUG; UNINDEXED DRUG; VP 14637; ZINC;

ACQUIRED IMMUNE DEFICIENCY SYNDROME; ACUTE OTITIS MEDIA; ADENOVIRUS; ANEMIA; ANTIGEN DETECTION; ASTHMA; BOCAVIRUS; BRONCHIOLITIS; CHRONIC OBSTRUCTIVE LUNG DISEASE; COMBINATION CHEMOTHERAPY; COMMON COLD; COMMUNITY ACQUIRED PNEUMONIA; CORONAVIRUS; CROUP; DRUG MECHANISM; DRUG MEGADOSE; ELECTROLYTE DISTURBANCE; FEVER; HEMATOLOGIC MALIGNANCY; HEMATOPOIETIC STEM CELL TRANSPLANTATION; HEMOLYTIC ANEMIA; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; HUMAN METAPNEUMOVIRUS; HUMAN RHINOVIRUS; IMMUNE DEFICIENCY; IMMUNOMODULATION; INFLUENZA; INFLUENZA VIRUS; KIDNEY DYSFUNCTION; LIVER DYSFUNCTION; MALAISE; MICROARRAY ANALYSIS; MONOTHERAPY; PARAINFLUENZA VIRUS; PARAMYXOVIRUS; PARVOVIRUS; PICORNAVIRUS; POLYMERASE CHAIN REACTION; RESPIRATORY FAILURE; RESPIRATORY SYNCYTIAL PNEUMOVIRUS; RESPIRATORY VIRUS; REVIEW; RNA INTERFERENCE; SEVERE ACUTE RESPIRATORY SYNDROME; SINUSITIS; SUICIDAL BEHAVIOR; THROMBOCYTOPENIA; UPPER RESPIRATORY TRACT INFECTION; VIRAL RESPIRATORY TRACT INFECTION; VIRUS ATTACHMENT; VIRUS CULTURE; VIRUS PNEUMONIA;

ANTIVIRAL AGENTS; BRONCHIAL DISEASES; COMMUNITY-ACQUIRED INFECTIONS; HUMANS; RESPIRATORY TRACT INFECTIONS; VIRUS DISEASES;

ORTHOMYXOVIRIDAE;

EID: 42349098907     PISSN: 08938512     EISSN: None     Source Type: Journal    
DOI: 10.1128/CMR.00045-07     Document Type: Review

References (244)

1. Alymova, I. V., G. Taylor, T. Takimoto, T. H. Lin, P. Chand, Y. S. Babu, C. Li, X. Xiong, and A. Portner. 2004. Efficacy of novel hemagglutinin-neuraminidase inhibitors BCX 2798 and BCX 2855 against human parainfluenza viruses in vitro and in vivo. Antimicrob. Agents Chemother. 48:1495-1502.
2. American Academy of Pediatrics Subcommittee on Diagnosis and Management of Bronchiolitis. 2006. Diagnosis and management of bronchiolitis. Pediatrics 118:1774-1793.
3. Angeles Marcos, M., M. Camps, T. Pumarola, J. Antonio Martinez, E. Martinez, J. Mensa, E. Garcia, G. Penarroja, P. Dambrava, I. Casas, M. T. Jimenez de Anta, and A. Torres. 2006. The role of viruses in the aetiology of community-acquired pneumonia in adults. Antiviral Ther. 11:351-359.
4. Arnold, J. C., K. K. Singh, S. A. Spector, and M. H. Sawyer. 2006. Human bocavirus: prevalence and clinical spectrum at a children's hospital. Clin. Infect. Dis. 43:283-288.
5. Aslan, T., A. B. Fassas, R. Desikan, D. Siegel, N. Munshi, J. Mehta, S. Singhal, B. Barlogie, and E. Anaissie. 1999. Patients with multiple myeloma may safely undergo autologous transplantation despite ongoing RSV infection and no ribavirin therapy. Bone Marrow Transplant. 24:505-509.
6. Barnard, D. L., C. W. Day, K. Bailey, M. Heiner, R. Montgomery, L. Lauridsen, P. K. Chan, and R. W. Sidwell. 2006. Evaluation of immunomodulators, interferons and known in vitro SARS-coV inhibitors for inhibition of SARS-coV replication in BALB/c mice. Antiviral Chem. Chemother. 17:275-284.
7. Barnard, D. L., V. D. Hubbard, J. Burton, D. F. Smee, J. D. Morrey, M. J. Otto, and R. W. Sidwell. 2004. Inhibition of severe acute respiratory syndrome-associated coronavirus (SARSCoV) by calpain inhibitors and beta-D-N4-hydroxycytidine. Antiviral Chem. Chemother. 15:15-22.
8. Belongia, E. A., R. Berg, and K. Liu. 2001. A randomized trial of zinc nasal spray for the treatment of upper respiratory illness in adults. Am. J. Med. 111:103-108.
9. Billings, J. L., M. I. Hertz, K. Savik, and C. H. Wendt. 2002. Respiratory viruses and chronic rejection in lung transplant recipients. J. Heart Lung Transplant. 21:559-566.
10. Bitko, V., A. Musiyenko, O. Shulyayeva, and S. Barik. 2005. Inhibition of respiratory viruses by nasally administered siRNA. Nat. Med. 11:50-55.
11. Bjornson, C., L., T. P. Klassen, J. Williamson, R. Brant, C. Mitton, A. Plint, B. Bulloch, L. Evered, and D. W. Johnson. 2004. A randomized trial of a single dose of oral dexamethasone for mild croup. N. Engl. J. Med. 351:1306-1313.
12. Blanchard, S. S., M. Gerrek, C. Siegel, and S. J. Czinn. 2006. Significant morbidity associated with RSV infection in immunosuppressed children following liver transplantation: case report and discussion regarding need of routine prophylaxis. Pediatr. Transplant. 10:826-829.
13. Boeckh, M., M. M. Berrey, R. A. Bowden, S. W. Crawford, J. Balsley, and L. Corey. 2001. Phase 1 evaluation of the respiratory syncytial virus-specific monoclonal antibody palivizumab in recipients of hematopoietic stem cell transplants. J. Infect. Dis. 184:350-354.
14. Boeckh, M., J. Englund, Y. Li, C. Miller, A. Cross, H. Fernandez, J. Kuypers, H. Kim, J. Gnann, and R. Whitley. 2007. Randomized controlled multicenter trial of aerosolized ribavirin for respiratory syncytial virus upper respiratory tract infection in hematopoietic cell transplant recipients. Clin. Infect. Dis. 44:245-249.
15. Boeckh, M., T. Gooley, J. Englund, J. Chien, S. W. Crawford, R. Bowden, and L. Corey. 2004. RSV infection in HCT recipients: risk factors for acquisition and tower tract disease, and impact on mortality. Blood 104:57a.
16. Boivin, G., Y. Abed, G. Pelletier, L. Ruel, D. Moisan, S. Cote, T. C. Peret, D. D. Erdman, and L. J. Anderson. 2002. Virological features and clinical manifestations associated with human metapneumovirus: a new paramyxovirus responsible for acute respiratory-tract infections in all age groups. J. Infect. Dis. 186:1330-1334.
17. Reference deleted.
18. Booth, C. M., L. M. Matukas, G. A. Tomlinson, A. R. Rachlis, D. B. Rose, H. A. Dwosh, S. L. Walmsley, T. Mazzulli, M. Avendano, P. Derkach, I. E. Ephtimios, I. Kitai, B. D. Mederski, S. B. Shadowitz, W. L. Gold, L. A. Hawryluck, E. Rea, J. S. Chenkin, D. W. Cescon, S. M. Poutanen, and A. S. Detsky. 2003. Clinical features and short-term outcomes of 144 patients with SARS in the greater Toronto area. JAMA 289:2801-2809.
19. Bosch, B. J., B. E. Martina, R. Van Der Zee, J. Lepault, B. J. Haijema, C. Versluis, A. J. Heck, R. De Groot, A. D. Osterhaus, and P. J. Rottier. 2004. Severe acute respiratory syndrome coronavirus (SARS-CoV) infection inhibition using spike protein heptad repeat-derived peptides. Proc. Natl. Acad. Sci. USA 101:8455-8460.
20. Bowden, R. A. 1997. Respiratory virus infections after marrow transplant: the Fred Hutchinson Cancer Research Center experience. Am. J. Med. 102:27-30, 42-43.
21. Boyce, T. G., B. G. Mellen, E. F. Mitchel, Jr., P. F. Wright, and M. R. Griffin. 2000. Rates of hospitalization for respiratory syncytial virus infection among children in Medicaid. J. Pediatr. 137:865-870.
22. Bridges, N. D., T. L. Spray, M. H. Collins, N. E. Bowles, and J. A. Towbin. 1998. Adenovirus infection in the lung results in graft failure after lung transplantation. J. Thorac. Cardiovasc. Surg. 116:617-623.
23. Bulkow, L. R., R. J. Singleton, R. A. Karron, and L. H. Harrison. 2002. Risk factors for severe respiratory syncytial virus infection among Alaska native children. Pediatrics 109:210-216.
24. Reference deleted.
25. Cardenas, S., A. Auais, and G. Piedimonte. 2005. Palivizumab in the prophylaxis of respiratory syncytial virus infection. Expert Rev. Anti-Infect. Ther. 3:719-726.
26. Chakrabarti, S., I. Avivi, S. Mackinnon, K. Ward, P. D. Kottaridis, H. Osman, H. Waldmann, G. Hale, C. D. Fegan, K. Yong, A. H. Goldstone, D. C. Linch, and D. W. Milligan. 2002. Respiratory virus infections in transplant recipients after reduced-intensity conditioning with Campath-1H: high incidence but low mortality. Br. J. Haematol. 119:1125-1132.
27. Chan, K. S., S. T. Lai, C. M. Chu, E. Tsui, C. Y. Tam, M. M. Wong, M. W. Tse, T. L. Que, J. S. Peiris, J. Sung, V. C. Wong, and K. Y. Yuen. 2003. Treatment of severe acute respiratory syndrome with lopinavir/ritonavir: a multicentre retrospective matched cohort study. Hong Kong Med. J. 9:399-406.
28. Chantzi, F. M., N. G. Papadopoulos, T. Bairamis, M. Tsiakou, N. Bournousouzis, A. G. Constantopoulos, G. Liapi, M. Xatzipsalti, and D. A. Kafetzis. 2006. Human rhinoviruses in otitis media with effusion. Pediatr. Allergy Immunol. 17:514-518.
29. Chapman, J., E. Abbott, D. G. Alber, R. C. Baxter, S. K. Bithell, E. A. Henderson, M. C. Carter, P. Chambers, A. Chubb, G. S. Cockerill, P. L. Collins, V. C. Dowdell, S. J. Keegan, R. D. Kelsey, M. J. Lockyer, C. Luongo, P. Najarro, R. J. Pickles, M. Simmonds, D. Taylor, S. Tyms, L. J. Wilson, and K. L. Powell. 2007. RSV604, a novel inhibitor of respiratory syncytial virus replication. Antimicrob. Agents Chemother. 51:3346-3353.
30. Chemaly, R. F., S. Ghosh, G. P. Bodey, N. Rohatgi, A. Safdar, M. J. Keating, R. E. Champlin, E. A. Aguilera, J. J. Tarrand, and I. I. Raad. 2006. Respiratory viral infections in adults with hematologic malignancies and human stem cell transplantation recipients: a retrospective study at a major cancer center. Medicine (Baltimore) 85:278-287.
31. Chen, F., K. H. Chan, Y. Jiang, R. Y. Kao, H. T. Lu, K. W. Fan, V. C. Cheng, W. H. Tsui, I. F. Hung, T. S. Lee, Y. Guan, J. S. Peiris, and K. Y. Yuen. 2004. In vitro susceptibility of 10 clinical isolates of SARS coronavirus to selected antiviral compounds. J. Clin. Virol. 31:69-75.
32. Chen, L., C. Gui, X. Luo, Q. Yang, S. Gunther, E. Scandella, C. Drosten, D. Bai, X. He, B. Ludewig, J. Chen, H. Luo, Y. Yang, Y. Yang, J. Zou, V. Thiel, K. Chen, J. Shen, X. Shen, and H. Jiang. 2005. Cinanserin is an inhibitor of the 3C-like proteinase of severe acute respiratory syndrome coronavirus and strongly reduces virus replication in vitro. J. Virol. 79:7095-7103.
33. Cheng, Y., R. Wong, Y. O. Soo, W. S. Wong, C. K. Lee, M. H. Ng, P. Chan, K. C. Wong, C. B. Leung, and G. Cheng. 2005. Use of convalescent plasma therapy in SARS patients in Hong Kong. Eur. J. Clin. Microbiol. Infect. Dis. 24:44-46.
34. Chiu, C. Y., A. A. Alizadeh, S. Rouskin, J. D. Merker, E. Yeh, S. Yagi, D. Schnurr, B. K. Patterson, D. Ganem, and J. L. Derisi. 2007. Diagnosis of a critical respiratory illness caused by human metapneumovirus by use of a pan-virus microarray. J. Clin. Microbiol. 45:2340-2343.
35. Chu, C. M., V. C. Cheng, I. F. Hung, M. M. Wong, K. H. Chan, K. S. Chan, R. Y. Kao, L. L. Poon, C. L. Wong, Y. Guan, J. S. Peiris, and K. Y. Yuen. 2004. Role of lopinavir/ritonavir in the treatment of SARS: initial virological and clinical findings. Thorax 59:252-256.
36. Ciesla, S. L., J. Trahan, W. B. Wan, J. R. Beadle, K. A. Aldern, G. R. Painter, and K. Y. Hostetler. 2003. Esterification of cidofovir with alkoxy-alkanols increases oral bioavailability and diminishes drug accumulation in kidney. Antiviral Res. 59:163-171.
37. Cinatl, J., Jr., M. Michaelis, M. Scholz, and H. W. Doerr. 2004. Role of interferons in the treatment of severe acute respiratory syndrome. Expert Opin. Biol. Ther. 4:827-836.
38. Cinatl, J., B. Morgenstern, G. Bauer, P. Chandra, H. Rabenau, and H. W. Doerr. 2003. Glycyrrhizin, an active component of liquorice roots, and replication of SARS-associated coronavirus. Lancet 361:2045-2046.
39. Coiras, M. T., P. Perez-Brena, M. L. Garcia, and I. Casas. 2003. Simultaneous detection of influenza A, B, and C viruses, respiratory syncytial virus, and adenoviruses in clinical samples by multiplex reverse transcription nested-PCR assay. J. Med. Virol. 69:132-144.
40. Corneli, H. M., J. J. Zorc, P. Majahan, K. N. Shaw, R. Holubkov, S. D. Reeves, R. M. Ruddy, B. Malik, K. A. Nelson, J. S. Bregstein, K. M. Brown, M. N. Denenberg, K. A. Lillis, L. B. Cimpello, J. W. Tsung, D. A. Borgialli, M. N. Baskin, G. Teshome, M. A. Goldstein, D. Monroe, J. M. Dean, and N. Kuppermann. 2007. A multicenter, randomized, controlled trial of dexamethasone for bronchiolitis. N. Engl. J. Med. 357:331-339.
41. Dales, N. A., A. E. Gould, J. A. Brown, E. F. Calderwood, B. Guan, C. A. Minor, J. M. Gavin, P. Hales, V. K. Kaushik, M. Stewart, P. J. Tummino, C. S. Vickers, T. D. Ocain, and M. A. Patane. 2002. Substrate-based design of the first class of angiotensin-converting enzyme-related carboxypeptidase (ACE2) inhibitors. J. Am. Chem. Soc. 124:11852-11853.
42. Dare, R., S. Sanghavi, A. Bullotta, M. C. Keightley, K. S. George, R. M. Wadowsky, D. L. Paterson, K. R. McCurry, T. A. Reinhart, S. Husain, and C. R. Rinaldo. 2007. Diagnosis of human metapneumovirus infection in immunosuppressed lung transplant recipients and children evaluated for pertussis. J. Clin. Microbiol. 45:548-552.
43. Denny, F. W., T. F. Murphy, W. A. Clyde, Jr., A. M. Collier, and F. W. Henderson. 1983. Croup: an 11-year study in a pediatric practice. Pediatrics 71:871-876.
44. Reference deleted.
45. DeVincenzo, J. P., J. Cehelsky, K. Foote, S. Nochur, A. Vaishnaw, and R. Meyers. 2007. Presented at the Pediatric Academic Societies' Annual Meeting Toronto, Ontario, Canada, May 5-8, 2007.
46. DeVincenzo, J. P., R. L. Hirsch, R. J. Fuentes, and F. H. Top. Jr. 2000. Respiratory syncytial virus immune globulin treatment of lower respiratory tract infection in pediatric patients undergoing bone marrow transplantation - a compassionate use experience. Bone Marrow Transplant. 25:161-165.
47. Dignan, F., C. Alvares, U. Riley, M. Ethell, D. Cunningham, J. Treleaven, S. Ashley, J. Bendig, G. Morgan, and M. Potter. 2006. Parainfluenza type 3 infection post stem cell transplant: high prevalence but low mortality. J. Hosp. Infect. 63:452-458.
48. Englund, J. A., M. Boeckh, J. Kuypers, W. G. Nichols, R. C. Hackman, R. A. Morrow, D. N. Fredricks, and L. Corey. 2006. Fatal human metapneumovirus infection in stem-cell transplant recipients. Ann. Intern. Med. 144:344-349.
49. Englund, J. A., P. A. Piedra, A. Jewell, K. Patel, B. B. Baxter, and E. Whimbey. 1996. Rapid diagnosis of respiratory syncytial virus infections in immunocompromised adults. J. Clin. Microbiol. 34:1649-1653.
50. Falsey, A. R. 2007. Respiratory syncytial virus infection in adults. Semin. Respir. Crit. Care Med. 28:171-181.
51. Falsey, A. R., M. C. Criddle, and E. E. Walsh. 2006. Detection of respiratory syncytial virus and human metapneumovirus by reverse transcription polymerase chain reaction in adults with and without respiratory illness. J. Clin. Virol. 35:46-50.
52. Falsey, A. R., P. A. Hennessey, M. A. Formica, C. Cox, and E. E. Walsh. 2005. Respiratory syncytial virus infection in elderly and high-risk adults. N. Engl. J. Med. 352:1749-1759.
53. Falsey, A. R., and E. E. Walsh. 2000. Respiratory syncytial virus infection in adults. Clin. Microbiol. Rev. 13:371-384.
54. Feltes, T. F., A. K. Cabalka, H. C. Meissner, F. M. Piazza, D. A. Carlin, F. H. Top, Jr., E. M. Connor, and H. M. Sondheimer. 2003. Palivizumab prophylaxis reduces hospitalization due to respiratory syncytial virus in young children with hemodynamically significant congenital heart disease. J. Pediatr. 143:532-540.
55. Fleischer, R., and K. Laessig. 2003. Safety and efficacy evaluation of pleconaril for treatment of the common cold. Clin. Infect. Dis. 37:1722.
56. Flomenberg, P., J. Babbitt, W. R. Drobyski, R. C. Ash, D. R. Carrigan, G. V. Sedmak, T. McAuliffe, B. Camitta, M. M. Horowitz, N. Bunin, et al. 1994. Increasing incidence of adenovirus disease in bone marrow transplant recipients. J. Infect. Dis. 169:775-781.
57. Fournier-Wirth, C., and J. Coste. 2007. Fitting new technologies into the safety paradigm: use of microarrays in transfusion. Dev. Biol. (Basel) 127:61-70.
58. Frank, J. A., Jr., R. W. Warren, J. A. Tucker, J. Zeller, and C. M. Wilfert. 1983. Disseminated parainfluenza infection in a child with severe combined immunodeficiency. Am. J. Dis. Child. 137:1172-1174.
59. Freymouth, F., A. Vabret, L. Legrand, N. Eterradossi, F. Lafay-Delaire, J. Brouard, and B. Guillois. 2003. Presence of the new human metapneumovirus in French children with bronchiolitis. Pediatr. Infect. Dis. J. 22:92-94.
60. Garbino, J., S. Crespo, J. D. Aubert, T. Rochat, B. Ninet, C. Deffernez, W. Wunderli, J. C. Pache, P. M. Soccal, and L. Kaiser. 2006. A prospective hospital-based study of the clinical impact of non-severe acute respiratory syndrome (non-SARS)-related human coronavirus infection. Clin. Infect. Dis. 43:1009-1015.
61. Gerna, G., G. Campanini, F. Rovida, E. Percivalle, A. Sarasini, A. Marchi, and F. Baldanti. 2006. Genetic variability of human coronavirus OC43-, 229E-, and NL63-like strains and their association with lower respiratory tract infections of hospitalized infants and immunocompromised patients. J. Med. Virol. 78:938-949.
62. Gerna, G., P. Vitulo, F. Rovida, D. Lilleri, C. Pellegrini, T. Oggionni, G. Campanini, F. Baldanti, and M. G. Revello. 2006. Impact of human metapneumovirus and human cytomegalovirus versus other respiratory viruses on the lower respiratory tract infections of lung transplant recipients. J. Med. Virol. 78:408-416.
63. Ghosh, S., R. Champlin, R. Couch, J. Englund, I. Raad, S. Malik, M. Luna, and E. Whimbey. 1999. Rhinovirus infections in myelosuppressed adult blood and marrow transplant recipients. Clin. Infect. Dis. 29:528-532.
64. Gilbert, B. E., and V. Knight. 1986. Biochemistry and clinical applications of ribavirin. Antimicrob. Agents Chemother. 30:201-205.
65. Greenberg, S. B. 2007. Rhinovirus and coronavirus infections. Semin. Respir. Crit. Care Med. 28:182-192.
66. Greensill, J., P. S. McNamara, W. Dove, B. Flanagan, R. L. Smyth, and C. A. Hart. 2003. Human metapneumovirus in severe respiratory syncytial virus bronchiolitis. Emerg. Infect. Dis. 9:372-375.
67. Groneberg, D. A., S. M. Poutanen, D. E. Low, H. Lode, T. Welte, and P. Zabel. 2005. Treatment and vaccines for severe acute respiratory syndrome. Lancet Infect. Dis. 5:147-155.
68. Groothuis, J. R., E. A. Simoes, V. G. Hemming, et al. 1995. Respiratory syncytial virus (RSV) infection in preterm infants and the protective effects of RSV immune globulin (RSVIG). Pediatrics 95:463-467.
69. Groothuis, J. R., E. A. Simoes, M. J. Levin, C. B. Hall, C. E. Long, W. J. Rodriguez, J. Arrobio, H. C. Meissner, D. R. Fulton, R. C. Welliver, et al. 1993. Prophylactic administration of respiratory syncytial virus immune globulin to high-risk infants and young children. N. Engl. J. Med. 329:1524-1530.
70. Haagmans, B. L., T. Kuiken, B. E. Martina, R. A. Fouchier, G. F. Rimmelzwaan, G. van Amerongen, D. van Riel, T. de Jong, S. Itamura, K. H. Chan, M. Tashiro, and A. D. Osterhaus. 2004. Pegylated interferon-alpha protects type 1 pneumocytes against SARS coronavirus infection in macaques. Nat. Med. 10:290-293.
71. Hall, C. B. 2001. Respiratory syncytial virus and parainfluenza virus. N. Engl. J. Med. 344:1917-1928.
72. Hamelin, M. E., G. A. Prince, and G. Boivin. 2006. Effect of ribavirin and glucocorticoid treatment in a mouse model of human metapneumovirus infection. Antimicrob. Agents Chemother. 50:774-777.
73. Harrington, R. D., T. M. Hooton, R. C. Hackman, G. A. Storch, B. Osborne, C. A. Gleaves, A. Benson, and J. D. Meyers. 1992. An outbreak of respiratory syncytial virus in a bone marrow transplant center. J. Infect. Dis. 165:987-993.
74. Hayden, F. G., J. K. Albrecht, D. L. Kaiser, and J. M. Gwaltney, Jr. 1986. Prevention of natural colds by contact prophylaxis with intranasal alpha 2-interferon. N. Engl. J. Med. 314:71-75.
75. Hayden, F. G., T. Coats, K. Kim, H. A. Hassman, M. M. Blatter, B. Zhang, and S. Liu. 2002. Oral pleconaril treatment of picornavirus- associated viral respiratory illness in adults: efficacy and tolerability in phase II clinical trials. Antiviral Ther. 7:53-65.
76. Hayden, F. G., D. T. Herrington, T. L. Coats, K. Kim, E. C. Cooper, S. A. Villano, S. Liu, S. Hudson, D. C. Pevear, M. Collett, and M. McKinlay. 2003. Efficacy and safety of oral pleconaril for treatment of colds due to picornaviruses in adults: results of 2 double-blind, randomized, placebo-controlled trials. Clin. Infect. Dis. 36:1523-1532.
77. Hayden, F. G., D. L. Kaiser, and J. K. Albrecht. 1988. Intranasal recombinant alfa-2b interferon treatment of naturally occurring common colds. Antimicrob. Agents Chemother. 32:224-230.
78. Hayden, F. G., R. B. Turner, J. M. Gwaltney, K. Chi-Burris, M. Gersten, P. Hsyu, A. K. Patick, G. J. Smith, 3rd, and L. S. Zalman. 2003. Phase II, randomized, double-blind, placebo-controlled studies of ruprintrivir nasal spray 2-percent suspension for prevention and treatment of experimentally induced rhinovirus colds in healthy volunteers. Antimicrob. Agents Chemother. 47:3907-3916.
79. Hayden, F. G., B. Winther, G. R. Donowitz, S. E. Mills, and D. J. Innes. 1987. Human nasal mucosal responses to topically applied recombinant leukocyte A interferon. J. Infect. Dis. 156:64-72.
80. Heagy, W., C. Crumpacker, P. A. Lopez, and R. W. Finberg. 1991. Inhibition of immune functions by antiviral drugs. J. Clin. Investig. 87:1916-1924.
81. Henrickson, K. J., S. Hoover, K. S. Kehl, and W. Hua. 2004. National disease burden of respiratory viruses detected in children by polymerase chain reaction. Pediatr. Infect. Dis. J. 23:S11-S18.
82. Hensley, L. E., L. E. Fritz, P. B. Jahrling, C. L. Karp, J. W. Huggins, and T. W. Geisbert. 2004. Interferon-beta 1a and SARS coronavirus replication. Emerg. Infect. Dis. 10:317-319.
83. Hindiyeh, M., D. R. Hillyard, and K. C. Carroll. 2001. Evaluation of the Prodesse Hexaplex multiplex PCR assay for direct detection of seven respiratory viruses in clinical specimens. Am. J. Clin. Pathol. 116:218-224.
84. Ho, J. C., A. Y. Wu, B. Lam, G. C. Ooi, P. L. Khong, P. L. Ho, M. Chan-Yeung, N. S. Zhong, C. Ko, W. K. Lam, and K. W. Tsang. 2004. Pentaglobin in steroid-resistant severe acute respiratory syndrome. Int. J. Tuberc. Lung Dis. 8:1173-1179.
85. Hsu, L. Y., C. C. Lee, J. A. Green, B. Ang, N. I. Paton, L. Lee, J. S. Villacian, P. L. Lim, A. Earnest, and Y. S. Leo. 2003. Severe acute respiratory syndrome (SARS) in Singapore: clinical features of index patient and initial contacts. Emerg. Infect. Dis. 9:713-717.
86. Huang, I. C., B. J. Bosch, F. Li, W. Li, K. H. Lee, S. Ghiran, N. Vasilieva, T. S. Dermody, S. C. Harrison, P. R. Dormitzer, M. Farzan, P. J. Rottier, and H. Choe. 2006. SARS coronavirus, but not human coronavirus NL63, utilizes cathepsin L to infect ACE2-expressing cells. J. Biol. Chem. 281:3198-3203.
87. Huang, L., D. J. Sexton, K. Skogerson, M. Devlin, R. Smith, I. Sanyal, T. Parry, R. Kent, J. Enright, Q. L. Wu, G. Conley, D. DeOliveira, L. Morganelli, M. Ducar, C. R. Wescott, and R. C. Ladner. 2003. Novel peptide inhibitors of angiotensin-converting enzyme 2. J. Biol. Chem. 278:15532-15540.
88. Humar, A., D. Kumar, T. Mazzulli, R. R. Razonable, G. Moussa, C. V. Paya, E. Covington, E. Alecock, and M. D. Pescovitz. 2005. A surveillance study of adenovirus infection in adult solid organ transplant recipients. Am. J. Transplant. 5:2555-2559.
89. IMpact-RSV Study Group. 1998. Palivizumab, a humanized respiratory syncytial virus monoclonal antibody, reduces hospitalization from respiratory syncytial virus infection in high-risk infants. Pediatrics 102:531-537.
90. Isaacs, A., and J. Lindenmann. 1957. Virus interference. Proc. R. Soc. London 147:258-267.
91. Ison, M. G. 2006. Adenovirus infections in transplant recipients. Clin. Infect. Dis. 43:331-339.
92. Ison, M. G., F. G. Hayden, L. Kaiser, L. Corey, and M. Boeckh. 2003. Rhinovirus infections in hematopoietic stem cell transplant recipients with pneumonia. Clin. Infect. Dis. 36:1139-1143.
93. Jackson, J. L., C. Peterson, and E. Lesho. 1997. A meta-analysis of zinc salts lozenges and the common cold. Arch. Intern. Med. 157:2373-2376.
94. Jennings, L. C., T. P. Anderson, K. A. Beynon, A. Chua, R. T. Laing, A. M. Werno, S. A. Young, S. T. Chambers, and D. R. Murdoch. 2008. Incidence and characteristics of viral community-acquired pneumonia in adults. Thorax 63:42-48.
95. Kaiser, L., J. D. Aubert, J. C. Pache, C. Deffernez, T. Rochat, J. Garbino, W. Wunderli, P. Meylan, S. Yerly, L. Perrin, I. Letovanec, L. Nicod, C. Tapparel, and P. M. Soccal. 2006. Chronic rhinoviral infection in lung transplant recipients. Am. J. Respir. Crit. Care Med. 174:1392-1399.
96. Kampmann, B., D. Cubitt, T. Walls, P. Naik, M. Depala, S. Samarasinghe, D. Robson, A. Hassan, K. Rao, H. Gaspar, G. Davies, A. Jones, C. Cale, K. Gilmour, M. Real, M. Foo, N. Bennett-Rees, A. Hewitt, P. Amrolia, and P. Veys. 2005. Improved outcome for children with disseminated adenoviral infection following allogeneic stem cell transplantation. Br. J. Haematol. 130:595-603.
97. Kaufman, S. S., M. S. Magid, A. Tschernia, N. S. LeLeiko, and T. M. Fishbein. 2002. Discrimination between acute rejection and adenoviral enteritis in intestinal transplant recipients. Transplant. Proc. 34:943-945.
98. Kehl, S. C., K. J. Henrickson, W. Hua, and J. Fan. 2001. Evaluation of the Hexaplex assay for detection of respiratory viruses in children. J. Clin. Microbiol. 39:1696-1701.
99. Keyaerts, E., L. Vijgen, L. Chen, P. Maes, G. Hedenstierna, and M. Van Ranst. 2004. Inhibition of SARS-coronavirus infection in vitro by S-nitroso-N-acetylpenicillamine, a nitric oxide donor compound. Int. J. Infect. Dis. 8:223-226.
100. Keyaerts, E., L. Vijgen, C. Pannecouque, E. Van Damme, W. Peumans, H. Egberink, J. Balzarini, and M. Van Ranst. 2007. Plant lectins are potent inhibitors of coronaviruses by interfering with two targets in the viral replication cycle. Antiviral Res. 75:179-187.
101. King, V. J., M. Viswanathan, W. C. Bordley, A. M. Jackman, S. F. Sutton, K. N. Lohr, and T. S. Carey. 2004. Pharmacologic treatment of bronchiolitis in infants and children: a systematic review. Arch. Pediatr. Adolesc. Med. 158:127-137.
102. Kliger, Y., and E. Y. Levanon. 2003. Cloaked similarity between HIV-1 and SARS-CoV suggests an anti-SARS strategy. BMC Microbiol. 3:20.
103. Knowles, S. R., E. J. Phillips, L. Dresser, and L. Matukas. 2003. Common adverse events associated with the use of ribavirin for severe acute respiratory syndrome in Canada. Clin. Infect. Dis. 37:1139-1142.
104. Ko, F. W., M. Ip, P. K. Chan, M. C. Chan, K. W. To, S. S. Ng, S. S. Chau, J. W. Tang, and D. S. Hui. 2007. Viral etiology of acute exacerbations of COPD in Hong Kong. Chest 132:900-908.
105. Ko, F. W., M. Ip, P. K. Chan, J. P. Fok, M. C. Chan, J. C. Ngai, D. P. Chan, and D. S. Hui. 2007. A 1-year prospective study of the infectious etiology in patients hospitalized with acute exacerbations of COPD. Chest 131:44-52.
106. Ko, F. W., W. Tam, T. W. Wong, D. P. Chan, A. H. Tung, C. K. Lai, and D. S. Hui. 2007. Temporal relationship between air pollutants and hospital admissions for chronic obstructive pulmonary disease in Hong Kong. Thorax 62:780-785.
107. Korant, B. D., J. C. Kauer, and B. E. Butterworth. 1974. Zinc ions inhibit replication of rhinoviruses. Nature 248:588-590.
108. Kumar, D., D. Erdman, S. Keshavjee, T. Peret, R. Tellier, D. Hadjiliadis, G. Johnson, M. Ayers, D. Siegal, and A. Humar. 2005. Clinical impact of community-acquired respiratory viruses on bronchiolitis obliterans after lung transplant. Am. J. Transplant. 5:2031-2036.
109. Larcher, C., C. Geltner, H. Fischer, D. Nachbaur, L. C. Muller, and H. P. Huemer. 2005. Human metapneumovirus infection in lung transplant recipients: clinical presentation and epidemiology. J. Heart Lung Transplant. 24:1891-1901.
110. Laurichesse, H., D. Dedman, J. M. Watson, and M. C. Zambon. 1999. Epidemiological features of parainfluenza virus infections: laboratory surveillance in England and Wales, 1975-1997. Eur. J. Epidemiol. 15:475-484.
111. Lawrence, M. C., N. A. Borg, V. A. Streltsov, P. A. Pilling, V. C. Epa, J. N. Varghese, J. L. McKimm-Breschkin, and P. M. Colman. 2004. Structure of the haemagglutinin-neuraminidase from human parainfluenza virus type III. J. Mol. Biol. 335:1343-1357.
112. Leader, S., and K. Kohlhase. 2002. Respiratory syncytial virus-coded pediatric hospitalizations, 1997 to 1999. Pediatr. Infect. Dis. J. 21:629-632.
113. Lee, N., D. Hui, A. Wu, P. Chan, P. Cameron, G. M. Joynt, A. Ahuja, M. Y. Yung, C. B. Leung, K. F. To, S. F. Lui, C. C. Szeto, S. Chung, and J. J. Sung. 2003. A major outbreak of severe acute respiratory syndrome in Hong Kong. N. Engl. J. Med. 348:1986-1994.
114. Lee, W. M., K. Grindle, T. Pappas, D. J. Marshall, M. J. Moser, E. L. Beaty, P. A. Shult, J. R. Prudent, and J. E. Gern. 2007. High-throughput, sensitive, and accurate multiplex PCR-microsphere flow cytometry system for large-scale comprehensive detection of respiratory viruses. J. Clin. Microbiol. 45:2626-2634.
115. Legrand, F., D. Berrebi, N. Houhou, F. Freymuth, A. Faye, M. Duval, J. F. Mougenot, M. Peuchmaur, and E. Vilmer. 2001. Early diagnosis of adenovirus infection and treatment with cidofovir after bone marrow transplantation in children. Bone Marrow Transplant. 27:621-626.
116. Lenaerts, L., and L. Naesens. 2006. Antiviral therapy for adenovirus infections. Antiviral. Res. 71:172-180.
117. Lewinsohn, D. M., R. A. Bowden, D. Mattson, and S. W. Crawford. 1996. Phase I study of intravenous ribavirin treatment of respiratory syncytial virus pneumonia after marrow transplantation. Antimicrob. Agents Chemother. 40:2555-2557.
118. Li, B. J., Q. Tang, D. Cheng, C. Qin, F. Y. Xie, Q. Wei, J. Xu, Y. Liu, B. J. Zheng, M. C. Woodle, N. Zhong, and P. Y. Lu. 2005. Using siRNA in prophylactic and therapeutic regimens against SARS coronavirus in rhesus macaque. Nat. Med. 11:944-951.
119. Li, W., M. J. Moore, N. Vasilieva, J. Sui, S. K. Wong, M. A. Berne, M. Somasundaran, J. L. Sullivan, K. Luzuriaga, T. C. Greenough, H. Choe, and M. Farzan. 2003. Angiotensin-converting enzyme 2 is a functional receptor for the SARS coronavirus. Nature 426:450-454.
120. Linde, K., B. Barrett, K. Wolkart, R. Bauer, and D. Melchart. 2006. Echinacea for preventing and treating the common cold. Cochrane Database Syst. Rev. 2006:CD000530.
121. Lion, T., R. Baumgartinger, F. Watzinger, S. Matthes-Martin, M. Suda, S. Preuner, B. Futterknecht, A. Lawitschka, C. Peters, U. Potschger, and H. Gadner. 2003. Molecular monitoring of adenovirus in peripheral blood after allogeneic bone marrow transplantation permits early diagnosis of disseminated disease. Blood 102:1114-1120.
122. Lion, T., S. Matthes-Martin, M. Suda, S. Preuner, F. Watzinger, A. Lawitschka, C. Peters, and H. Gadner. 2003. Intestinal adenovirus infection with increasing viral load in stool is an early indicator of impending disseminated disease in children undergoing T-cell depleted allogeneic stem cell transplantation. Blood 102:196a.
123. Liu, H. H., X. Cao, Y. Yang, M. G. Liu, and Y. F. Wang. 2006. Array-based nano-amplification technique was applied in detection of hepatitis E virus. J. Bioehem. Mol. Biol. 39:247-252.
124. Liu, S., G. Xiao, Y. Chen, Y. He, J. Niu, C. R. Escalante, H. Xiong, J. Farmar, A. K. Debnath, P. Tien, and S. Jiang. 2004. Interaction between heptad repeat 1 and 2 regions in spike protein of SARS-associated coronavirus: implications for virus fusogenic mechanism and identification of fusion inhibitors. Lancet 363:938-947.
125. Ljungman, P. 2001. Respiratory virus infections in stem cell transplant patients: the European experience. Biol Blood Marrow Transplant. 7(Suppl.):5S-7S.
126. Ljungman, P. 2004. Treatment of adenovirus infections in the immunocompromised host. Eur. J. Clin. Microbiol. Infect. Dis. 23:583-588.
127. Ljungman, P., P. Ribaud, M. Eyrich, S. Matthes-Martin, H. Einsele, M. Bleakley, M. Machaczka, M. Bierings, A. Bosi, N. Gratecos, and C. Cordonnier. 2003. Cidofovir for adenovirus infections after allogeneic hematopoietic stem cell transplantation: a survey by the Infectious Diseases Working Party of the European Group for Blood and Marrow Transplantation. Bone Marrow Transplant. 31:481-486.
128. Ljungman, P., K. N. Ward, B. N. Crooks, A. Parker, R. Martino, P. J. Shaw, L. Brinch, M. Brune, R. De La Camara, A. Dekker, K. Pauksen, N. Russell, A. P. Schwerer, and C. Cordonnier. 2001. Respiratory virus infections after stem cell transplantation: a prospective study from the Infectious Diseases Working Party of the European Group for Blood and Marrow Transplantation. Bone Marrow Transplant. 28:479-484.
129. Louie, J. K., J. K. Hacker, R. Gonzales, J. Mark, J. H. Maselli, S. Yagi, and W. L. Drew. 2005. Characterization of viral agents causing acute respiratory infection in a San Francisco University Medical Center Clinic during the influenza season. Clin. Infect. Dis. 41:822-828.
130. Loutfy, M. R., L. M. Blatt, K. A. Siminovitch, S. Ward, B. Wolff, H. Lho, D. H. Pham, H. Deif, E. A. LaMere, M. Chang, K. C. Kain, G. A. Farcas, P. Ferguson, M. Latchford, G. Levy, J. W. Dennis, E. K. Lai, and E. N. Fish. 2003. Interferon alfacon-1 plus corticosteroids in severe acute respiratory syndrome: a preliminary study. JAMA 290:3222-3228.
131. Luttick, A., B. Lin, C. Morton, S. Tucker, S. Bond, A. Draffan, J. Lambert, C.-Y. Lim, J. Mitchell, V. Sanford, M. McCarthy, J. Suzich, N. Patel, and B. Richter. 2007. Characterization of a new class of polycyclic RSV inhibitors. Antiviral Res. 74:A66.
132. Madhi, S. A., L. Kuwanda, C. Cutland, and K. P. Klugman. 2006. Five-year cohort study of hospitalization for respiratory syncytial virus associated lower respiratory tract infection in African children. J. Clin. Virol. 36:215-221.
133. Madhi, S. A., N. Ramasamy, T. G. Bessellar, H. Saloojee, and K. P. Klugman. 2002. Lower respiratory tract infections associated with influenza A and B viruses in an area with a high prevalence of pediatric human immunodeficiency type 1 infection. Pediatr. Infect. Dis. J. 21:291-297.
134. Madhi, S. A., B. Schoub, K. Simmank, N. Blackburn, and K. P. Klugman. 2000. Increased burden of respiratory viral associated severe lower respiratory tract infections in children infected with human immunodeficiency virus type-1. J. Pediatr. 137:78-84.
135. Madhi, S. A., M. Venter, A. Madhi, M. K. Petersen, and K. P. Klugman. 2001. Differing manifestations of respiratory syncytial virus-associated severe lower respiratory tract infections in human immunodeficiency virus type 1-infected and uninfected children. Pediatr. Infect. Dis. J. 20:164-170.
136. Mahony, J., S. Chong, F. Merante, S. Yaghoubian, T. Sinha, C. Lisle, and R. Janeczko. 2007. Development of a respiratory virus panel test for detection of 20 human respiratory viruses by use of multiplex PCR and a fluid microbead-based assay. J. Clin. Microbiol. 45:2965-2970.
137. Malcolm, E., E. Arruda, F. G. Hayden, and L. Kaiser. 2001. Clinical features of patients with acute respiratory illness and rhinovirus in their bronchoalveolar lavages. J. Clin. Virol. 21:9-16.
138. Meert, K. L., A. P. Sarnaik, M. J. Gelmini, and M. W. Lieh-Lai. 1994. Aerosolized ribavirin in mechanically ventilated children with respiratory syncytial virus lower respiratory tract disease: a prospective, double-blind, randomized trial. Crit. Care Med. 22:566-572.
139. Meissner, H. C. 2003. Selected populations at increased risk from respiratory syncytial virus infection. Pediatr. Infect. Dis. J. 22:S40-S45.
140. Mendoza Sanchez, M. C., J. Ruiz-Contreras, J. L. Vivanco, F. Fernandez-Carrion, M. Baro Fernandez, J. T. Ramos, J. R. Otero, and D. Folgueira. 2006. Respiratory virus infections in children with cancer or HIV infection. J. Pediatr. Hematol Oncol. 28:154-159.
141. Michaels, M. G., M. Green, E. R. Wald, and T. E. Starzl. 1992. Adenovirus infection in pediatric liver transplant recipients. J. Infect. Dis. 165:170-174.
142. Monto, A. S., A. M. Fendrick, and M. W. Sarnes. 2001. Respiratory illness caused by picornavirus infection: a review of clinical outcomes. Clin. Ther. 23:1615-1627.
143. Morfin, F., S. Dupuis-Girod, S. Mundweiler, D. Falcon, D. Carrington, P. Sedlacek, M. Bierings, P. Cetkovsky, A. C. Kroes, M. J. van Tol, and D. Thouvenot. 2005. In vitro susceptibility of adenovirus to antiviral drugs is species-dependent. Antiviral Ther. 10:225-229.
144. Morgenstern, B., M. Michaelis, P. C. Baer, H. W. Doerr, and J. Cinatl, Jr. 2005. Ribavirin and interferon-beta synergistically inhibit SARS-associated coronavirus replication in animal and human cell lines. Biochem. Biophys. Res. Commun. 326:905-908.
145. Mossad, S. B. 2003. Effect of zincum gluconicum nasal gel on the duration and symptom severity of the common cold in otherwise healthy adults. QJM 96:35-43.
146. Munir, S., K. Kaur, and V. Kapur. 2006. Avian metapneumovirus phosphoprotein targeted RNA interference silences the expression of viral proteins and inhibits virus replication. Antiviral Res. 69:46-51.
147. Naesens, L., L. Lenaerts, G. Andrei, R. Snoeck, D. Van Beers, A. Holy, J. Balzarini, and E. De Clercq. 2005. Antiadenovirus activities of several classes of nucleoside and nucleotide analogues. Antimicrob. Agents Chemother. 49:1010-1016.
148. Nagafuji, K., K. Aoki, H. Henzan, K. Kato, T. Miyamoto, T. Eto, Y. Nagatoshi, T. Ohba, K. Obama, H. Gondo, and M. Harada. 2004. Cidofovir for treating adenoviral hemorrhagic cystitis in hematopoietic stem cell transplant recipients. Bone Marrow Transplant. 34:909-914.
149. Navas, L., E. Wang, V. de Carvalho, J. Robinson, et al. 1992. Improved outcome of respiratory syncytial virus infection in a high-risk hospitalized population of Canadian children. J. Pediatr. 121:348-354.
150. Neofytos, D., A. Ojha, B. Mookerjee, J. Wagner, J. Filicko, A. Ferber, S. Dessain, D. Grosso, J. Brunner, N. Flomenberg, and P. Flomenberg. 2007. Treatment of adenovirus disease in stem cell transplant recipients with cidofovir. Biol. Blood Marrow Transplant. 13:74-81.
151. Nichols, W. G., L. Corey, T. Gooley, C. Davis, and M. Boeckh. 2001. Parainfluenzavirus infections after hematopoietic stem cell transplantation: risk factors, response to antiviral therapy, and effect on transplant outcome. Blood 98:573-578.
152. Nichols, W. G., T. Gooley, and M. Boeckh. 2001. Community-acquired respiratory syncytial virus and parainfluenza virus infections after hematopoietic stem cell transplantation: the Fred Hutchinson Cancer Research Center experience. Biol. Blood Marrow Transplant. 7(Suppl.):11S-15S.
153. Nolte, F. S., D. J. Marshall, C. Rasberry, S. Schievelbein, G. G. Banks, G. A. Storch, M. Q. Arens, R. S. Buller, and J. R. Prudent. 2007. MultiCode-PLx system for multiplexed detection of 17 respiratory viruses. J. Clin. Microbiol. 45:2779-2786.
154. Novick, S. G., J. C. Godfrey, N. J. Godfrey, and H. R. Wilder. 1996. How does zinc modify the common cold? Clinical observations and implications regarding mechanisms of action. Med. Hypotheses 46:295-302.
155. Noyola, D. E., A. Zuviri-Gonzalez, J. A. Castro-Garcia, and J. R. Ochoa-Zavala. 2007. Impact of respiratory syncytial virus on hospital admissions in children younger than 3 years of age. J. Infect. 54:180-184.
156. Ohori, N. P., M. G. Michaels, R. Jaffe, P. Williams, and S. A. Yousem. 1995. Adenovirus pneumonia in lung transplant recipients. Hum. Pathol. 26:1073-1079.
157. Patel, H., R. Platt, J. M. Lozano, and E. E. Wang. 2004. Glucocorticoids for acute viral bronchiolitis in infants and young children. Cochrane Database Syst. Rev. 2004:CD004878.
158. Patel, J. A., D. T. Nguyen, K. Revai, and T. Chonmaitree. 2007. Role of respiratory syncytial virus in acute otitis media: implications for vaccine development. Vaccine 25:1683-1689.
159. Patick, A. K. 2006. Rhinovirus chemotherapy. Antiviral Res. 71:391-396.
160. Patick, A. K., M. A. Brothers, F. Maldonado, S. Binford, O. Maldonado, S. Fuhrman, A. Petersen, G. J. Smith III, L. S. Zalman, L. A. Burns-Naas, and J. Q. Tran. 2005. In vitro antiviral activity and single-dose pharmacokinetics in humans of a novel, orally bioavailable inhibitor of human rhinovirus 3C protease. Antimicrob. Agents Chemother. 49:2267-2275.
161. Peck, A. J., L. Corey, and M. Boeckh. 2004. Pretransplantation respiratory syncytial virus infection: impact of a strategy to delay transplantation. Clin. Infect. Dis. 39:673-680.
162. Peck, A. J., J. A. Englund, J. Kuypers, K. A. Guthrie, L. Corey, R. Morrow, R. C. Hackman, A. Cent, and M. Boeckh. 2007. Respiratory virus infection among hematopoietic cell transplant recipients: evidence for asymptomatic parainfluenza virus infection. Blood 110:1681-1688.
163. Peck, A. J., R. C. Holman, A. T. Curns, J. R. Lingappa, J. E. Cheek, R. J. Singleton, K. Carver, and L. J. Anderson. 2005. Lower respiratory tract infections among American Indian and Alaska Native children and the general population of U.S. children. Pediatr. Infect. Dis. J. 24:342-351.
164. Peigue-Lafeuille, H., N. Gazuy, P. Mignot, P. Deteix, D. Beytout, and J. C. Baguet. 1990. Severe respiratory syncytial virus pneumonia in an adult renal transplant recipient: successful treatment with ribavirin. Scand. J. Infect. Dis. 22:87-89.
165. Peiris, J. S., C. M. Chu, V. C. Cheng, K. S. Chan, I. F. Hung, L. L. Poon, K. I. Law, B. S. Tang, T. Y. Hon, C. S. Chan, K. H. Chan, J. S. Ng, B. J. Zheng, W. L. Ng, R. W. Lai, Y. Guan, and K. Y. Yuen. 2003. Clinical progression and viral load in a community outbreak of coronavirus-associated SARS pneumonia: a prospective study. Lancet 361:1767-1772.
166. Peltola, V., T. Heikkinen, and O. Ruuskanen. 2002. Clinical courses of croup caused by influenza and parainfluenza viruses. Pediatr. Infect. Dis. J. 21:76-78.
167. Pevear, D. C., F. G. Hayden, T. M. Demenczuk, L. R. Barone, M. A. McKinlay, and M. S. Collett. 2005. Relationship of pleconaril susceptibility and clinical outcomes in treatment of common colds caused by rhinoviruses. Antimicrob. Agents Chemother. 49:4492-4499.
168. Pinchoff, R. J., S. S. Kaufman, M. S. Magid, D. D. Erdman, G. E. Gondolesi, M. H. Mendelson, K. Tane, S. G. Jenkins, T. M. Fishbein, and B. C. Herold. 2003. Adenovirus infection in pediatric small bowel transplantation recipients. Transplantation 76:183-189.
169. Pitkaranta, A., and F. G. Hayden. 1998. What's new with common colds? Infect. Med. 15:50-59.
170. Pohl, C., M. Green, E. R. Wald, and J. Ledesma-Medina. 1992. Respiratory syncytial virus infections in pediatric liver transplant recipients. J. Infect. Dis. 165:166-169.
171. Porotto, M., M. Fornabaio, G. E. Kellogg, and A. Moscona. 2007. A second receptor binding site on human parainfluenza virus type 3 hemagglutinin-neuraminidase contributes to activation of the fusion mechanism. J. Virol. 81:3216-3228.
172. Porotto, M., M. Murrell, O. Greengard, M. C. Lawrence, J. L. McKimm-Breschkin, and A. Moscona. 2004. Inhibition of parainfluenza virus type 3 and Newcastle disease virus hemagglutinin-neuraminidase receptor binding: effect of receptor avidity and steric hindrance at the inhibitor binding sites. J. Virol. 78:13911-13919.
173. Proud, D., and C. W. Chow. 2006. Role of viral infections in asthma and chronic obstructive pulmonary disease. Am. J. Respir. Cell Mol. Biol. 35:513-518.
174. Pyrc, K., B. Berkhout, and L. van der Hoek. 2007. Identification of new human coronaviruses. Expert Rev. Anti-Infect. Ther. 5:245-253.
175. Quenelle, D. C., D. J. Collins, W. B. Wan, J. R. Beadle, K. Y. Hostetler, and E. R. Kern. 2004. Oral treatment of cowpox and vaccinia virus infections in mice with ether lipid esters of cidofovir. Antimicrob. Agents Chemother. 48:404-412.
176. Revai, K., L. A. Dobbs, S. Nair, J. A. Patel, J. J. Grady, and T. Chonmaitree. 2007. Incidence of acute otitis media and sinusitis complicating upper respiratory tract infection: the effect of age. Pediatrics 119:e1408-e1412.
177. Roberts, A., W. D. Thomas, J. Guarner, E. W. Lamirande, G. J. Babcock, T. C. Greenough, L. Vogel, N. Hayes, J. L. Sullivan, S. Zaki, K. Subbarao, and D. M. Ambrosino. 2006. Therapy with a severe acute respiratory syndrome-associated coronavirus-neutralizing human monoclonal antibody reduces disease severity and viral burden in golden Syrian hamsters. J. Infect. Dis. 193:685-692.
178. Rosekrans, J. A. 1998. Viral croup: current diagnosis and treatment. Mayo Clin. Proc. 73:1102-1107.
179. Rossi, G. A., M. C. Medici, M. C. Arcangeletti, M. Lanari, R. Merolla, U. D. Paparatti, M. Silvestri, A. Pistorio, and C. Chezzi. 2007. Risk factors for severe RSV-induced lower respiratory tract infection over four consecutive epidemics. Eur. J. Pediatr. 166:1267-1272.
180. Russell, K., N. Wiebe, A. Saenz, S. M. Ausejo, D. Johnson, L. Hartling, and T. P. Klassen. 2004. Glucocorticoids for croup. Cochrane Database Syst. Rev. 2004:CD001955.
181. Sainz, B., Jr., E. C. Mossel, C. J. Peters, and R. F. Garry. 2004. Interferon-beta and interferon-gamma synergistically inhibit the replication of severe acute respiratory syndrome-associated coronavirus (SARS-CoV). Virology 329:11-17.
182. Scagnolari, C., E. Vicenzi, F. Bellomi, M. G. Stillitano, D. Pinna, G. Poli, M. Clementi, F. Dianzani, and G. Antonelli. 2004. Increased sensitivity of SARS-coronavirus to a combination of human type I and type II interferons. Antiviral Ther. 9:1003-1011.
183. Schaller, M., C. M. Hogaboam, N. Lukacs, and S. L. Kunkel. 2006. Respiratory viral infections drive chemokine expression and exacerbate the asthmatic response. J. Allergy Clin. Immunol. 118:295-304.
184. Reference deleted.
185. Schleuning, M., H. Buxbaum-Conradi, G. Jager, and H. J. Kolb. 2004. Intravenous ribavirin for eradication of respiratory syncytial virus (RSV) and adenovirus isolates from the respiratory and/or gastrointestinal tract in recipients of allogeneic hematopoietic stem cell transplants. Hematol. J. 5:135-144.
186. Seemungal, T., R. Harper-Owen, A. Bhowmik, I. Moric, G. Sanderson, S. Message, P. Maccallum, T. W. Meade, D. J. Jeffries, S. L. Johnston, and J. A. Wedzicha. 2001. Respiratory viruses, symptoms, and inflammatory markers in acute exacerbations and stable chronic obstructive pulmonary disease. Am. J. Respir. Crit. Care Med. 164:1618-1623.
187. Shirali, G. S., J. Ni, R. E. Chinnock, J. K. Johnston, G. L. Rosenthal, N. E. Bowles, and J. A. Towbin. 2001. Association of viral genome with graft loss in children after cardiac transplantation. N. Engl. J. Med. 344:1498-1503.
188. Simmons, G., D. N. Gosalia, A. J. Rennekamp, J. D. Reeves, S. L. Diamond, and P. Bates. 2005. Inhibitors of cathepsin L prevent severe acute respiratory syndrome coronavirus entry. Proc. Natl. Acad. Sci. USA 102:11876-11881.
189. Simoes, E. A., J. R. Groothuis, D. A. Tristram, K. Allessi, M. V. Lehr, G. R. Siber, and R. C. Welliver. 1996. Respiratory syncytial virus-enriched globulin for the prevention of acute otitis media in high risk children. J. Pediatr. 129:214-219.
190. Singh, A. M., P. E. Moore, J. E. Gern, R. F. Lemanske, Jr., and T. V. Hartert. 2007. Bronchiolitis to asthma: a review and call for studies of gene-virus interactions in asthma causation. Am. J. Respir. Crit. Care Med. 175:108-119.
191. Sinnott, J. T., IV, J. P. Cullison, M. S. Sweeney, M. Hammond, and D. A. Holt. 1988. Respiratory syncytial virus pneumonia in a cardiac transplant recipient. J. Infect. Dis. 158:650-651.
192. Small, T. N., A. Casson, S. F. Malak, F. Boulad, T. E. Kiehn, J. Stiles, H. M. Ushay, and K. A. Sepkowitz. 2002. Respiratory syncytial virus infection following hematopoietic stem cell transplantation. Bone Marrow Transplant. 29:321-327.
193. Smith, D. W., L. R. Frankel, L. H. Mathers, A. T. Tang, R. L. Ariagno, and C. G. Prober. 1991. A controlled trial of aerosolized ribavirin in infants receiving mechanical ventilation for severe respiratory syncytial virus infection. N. Engl. J. Med. 325:24-29.
194. Snell, N. J. 2001. Ribavirin - current status of a broad spectrum antiviral agent. Expert Opin. Pharmacother. 2:1317-1324.
195. Soo, Y. O., Y. Cheng, R. Wong, D. S. Hui, C. K. Lee, K. K. Tsang, M. H. Ng, P. Chan, G. Cheng, and J. J. Sung. 2004. Retrospective comparison of convalescent plasma with continuing high-dose methylprednisolone treatment in SARS patients. Clin. Microbiol. Infect. 10:676-678.
196. Sparrelid, E., P. Ljungman, E. Ekelof-Andstrom, J. Aschan, O. Ringden, J. Winiarski, B. Wahlin, and J. Andersson. 1997. Ribavirin therapy in bone marrow transplant recipients with viral respiratory tract infections. Bone Marrow Transplant. 19:905-908.
197. Sperber, S. J., and F. G. Hayden. 1988. Chemotherapy of rhinovirus colds. Antimicrob. Agents Chemother. 32:409-419.
198. Spiegel, M., A. Pichlmair, E. Muhlberger, O. Haller, and F. Weber. 2004. The antiviral effect of interferon-beta against SARS-coronavirus is not mediated by MxA protein. J. Clin. Virol. 30:211-213.
199. Reference deleted.
200. Stockman, L. J., R. Bellamy, and P. Garner. 2006. SARS: systematic review of treatment effects. PLoS Med. 3:e343.
201. Stroher, U., A. DiCaro, Y. Li, J. E. Strong, F. Aoki, F. Plummer, S. M. Jones, and H. Feldmann. 2004. Severe acute respiratory syndrome-related coronavirus is inhibited by interferon-alpha. J. Infect. Dis. 189:1164-1167.
202. Subbarao, K., J. McAuliffe, L. Vogel, G. Fahle, S. Fischer, K. Tatti, M. Packard, W. J. Shieh, S. Zaki, and B. Murphy. 2004. Prior infection and passive transfer of neutralizing antibody prevent replication of severe acute respiratory syndrome coronavirus in the respiratory tract of mice. J. Virol. 78:3572-3577.
203. Sui, J., W. Li, A. Murakami, A. Tamin, L. J. Matthews, S. K. Wong, M. J. Moore, A. S. Tallarico, M. Olurinde, H. Choe, L. J. Anderson, W. J. Bellini, M. Farzan, and W. A. Marasco. 2004. Potent neutralization of severe acute respiratory syndrome (SARS) coronavirus by a human mAb to S1 protein that blocks receptor association. Proc. Natl. Acad. Sci. USA 101:2536-2541.
204. Sung, J. J., A. Wu, G. M. Joynt, K. Y. Yuen, N. Lee, P. K. Chan, C. S. Cockram, A. T. Ahuja, L. M. Yu, V. W. Wong, and D. S. Hui. 2004. Severe acute respiratory syndrome: report of treatment and outcome after a major outbreak. Thorax 59:414-420.
205. Tam, R. C., J. Y. Lau, and Z. Hong. 2001. Mechanisms of action of ribavirin in antiviral therapies. Antiviral Chem. Chemother. 12:261-272.
206. Tan, E. L., E. E. Ooi, C. Y. Lin, H. C. Tan, A. E. Ling, B. Lim, and L. W. Stanton. 2004. Inhibition of SARS coronavirus infection in vitro with clinically approved antiviral drugs. Emerg. Infect. Dis. 10:581-586.
207. Tanner, J. A., B. J. Zheng, J. Zhou, R. M. Watt, J. Q. Jiang, K. L. Wong, Y. P. Lin, L. Y. Lu, M. L. He, H. F. Kung, A. J. Kesel, and J. D. Huang. 2005. The adamantane-derived bananins are potent inhibitors of the helicase activities and replication of SARS coronavirus. Chem. Biol. 12:303-311.
208. ter Meulen, J., A. B. Bakker, E. N. van den Brink, G. J. Weverling, B. E. Martina, B. L. Haagmans, T. Kuiken, J. de Kruif, W. Preiser, W. Spaan, H. R. Gelderblom, J. Goudsmit, and A. D. Osterhaus. 2004. Human monoclonal antibody as prophylaxis for SARS coronavirus infection in ferrets. Lancet 363:2139-2141.
209. Tsang, K. W., P. L. Ho, G. C. Ooi, W. K. Yee, T. Wang, M. Chan-Yeung, W. K. Lam, W. H. Seto, L. Y. Yam, T. M. Cheung, P. C. Wong, B. Lam, M. S. Ip, J. Chan, K. Y. Yuen, and K. N. Lai. 2003. A cluster of cases of severe acute respiratory syndrome in Hong Kong. N. Engl. J. Med. 348:1977-1985.
210. Tsui, P. T., M. L. Kwok, H. Yuen, and S. T. Lai. 2003. Severe acute respiratory syndrome: clinical outcome and prognostic correlates. Emerg. Infect. Dis. 9:1064-1069.
211. Turner, R. B. 2001. Ineffectiveness of intranasal zinc gluconate for prevention of experimental rhinovirus colds. Clin. Infect. Dis. 33:1865-1870.
212. Turner, R. B., R. Bauer, K. Woelkart, T. C. Hulsey, and J. D. Gangemi. 2005. An evaluation of Echinacea angustifolia in experimental rhinovirus infections. N. Engl. J. Med. 353:341-348.
213. Turner, R. B., M. T. Wecker, G. Pohl, T. J. Witek, E. McNally, R. St. George, B. Winther, and F. G. Hayden. 1999. Efficacy of tremacamra, a soluble intercellular adhesion molecule 1, for experimental rhinovirus infection: a randomized clinical trial. JAMA 281:1797-1804.
214. Ulbrandt, N. D., H. Ji, N. K. Patel, J. M. Riggs, Y. A. Brewah, S. Ready, N. E. Donacki, K. Folliot, A. S. Barnes, K. Senthil, S. Wilson, M. Chen, L. Clarke, M. MacPhail, J. Li, R. M. Woods, K. Coelingh, J. L. Reed, M. P. McCarthy, D. S. Pfarr, A. D. Osterhaus, R. A. Fouchier, P. A. Kiener, and J. A. Suzich. 2006. Isolation and characterization of monoclonal antibodies which neutralize human metapneumovirus in vitro and in vivo. J. Virol. 80:7799-7806.
215. van der Hoek, L., K. Sure, G. Ihorst, A. Stang, K. Pyrc, M. F. Jebbink, G. Petersen, J. Forster, B. Berkhout, and K. Uberla. 2005. Croup is associated with the novel coronavirus NL63. PLoS Med. 2:e240.
216. Ventre, K., and A. G. Randolph. 2007. Ribavirin for respiratory syncytial virus infection of the lower respiratory tract in infants and young children. Cochrane Database Syst. Rev. 2007:CD000181.
217. Vilchez, R. A., K. McCurry, J. Dauber, A. Iacono, R. Keenan, A. Zeevi, B. Griffith, and S. Kusne. 2001. The epidemiology of parainfluenza virus infection in lung transplant recipients. Clin. Infect. Dis. 33:2004-2008.
218. Wadell, G., T. M. Varsanyi, A. Lord, and R. N. Sutton. 1980. Epidemic outbreaks of adenovirus 7 with special reference to the pathogenicity of adenovirus genome type 7b. Am. J. Epidemiol. 112:619-628.
219. Wallot, M. A., C. Dohna-Schwake, M. Auth, S. Nadalin, M. Fiedler, M. Malago, C. Broelsch, and T. Voit. 2006. Disseminated adenovirus infection with respiratory failure in pediatric liver transplant recipients: impact of intravenous cidofovir and inhaled nitric oxide. Pediatr. Transplant. 10:121-127.
220. Wang, E. E., B. J. Law, and D. Stephens. 1995. Pediatric Investigators Collaborative Network on Infections in Canada (PICNIC) prospective study of risk factors and outcomes in patients hospitalized with respiratory syncytial viral lower respiratory tract infection. J. Pediatr. 126:212-219.
221. Wang, J. T., W. H. Sheng, C. T. Fang, Y. C. Chen, J. L. Wang, C. J. Yu, S. C. Chang, and P. C. Yang. 2004. Clinical manifestations, laboratory findings, and treatment outcomes of SARS patients. Emerg. Infect. Dis. 10:818-824.
222. Welliver, T. P., R. P. Garofalo, Y. Hosakote, K. H. Hintz, L. Avendano, K. Sanchez, L. Velozo, H. Jafri, S. Chavez-Bueno, P. L. Ogra, L. McKinney, J. L. Reed, and R. C. Welliver, Sr. 2007. Severe human lower respiratory tract illness caused by respiratory syncytial virus and influenza virus is characterized by the absence of pulmonary cytotoxic lymphocyte responses. J. Infect. Dis. 195:1126-1136.
223. Weltzin, R. 1998. The therapeutic potential of monoclonal antibodies against respiratory syncytial virus. Expert Opin. Investig. Drugs. 7:1271-1283.
224. Wendt, C. H. 1997. Community respiratory viruses: organ transplant recipients. Am. J. Med. 102:31-36, 42-43.
225. Wendt, C. H., J. M. Fox, and M. I. Hertz. 1995. Paramyxovirus infection in lung transplant recipients. J. Heart Lung Transplant. 14:479-485.
226. Wendt, C. H., and M. I. Hertz. 1995. Respiratory syncytial virus and parainfluenza virus infections in the immunocompromised host. Semin. Respir. Infect. 10:224-231.
227. Wendt, C. H., D. J. Weisdorf, M. C. Jordan, H. H. Balfour, Jr., and M. I. Hertz. 1992. Parainfluenza virus respiratory infection after bone marrow transplantation. N. Engl. J. Med. 326:921-926.
228. Whimbey, E., R. E. Champlin, J. A. Englund, N. Q. Mirza, P. A. Piedra, J. M. Goodrich, D. Przepiorka, M. A. Luna, R. C. Morice, J. L. Neumann, et al. 1995. Combination therapy with aerosolized ribavirin and intravenous immunoglobulin for respiratory syncytial virus disease in adult bone marrow transplant recipients. Bone Marrow Transplant. 16:393-399.
229. Whimbey, E., R. B. Couch, J. A. Englund, M. Andreeff, J. M. Goodrich, I. I. Raad, V. Lewis, N. Mirza, M. A. Luna, B. Baxter, et al. 1995. Respiratory syncytial virus pneumonia in hospitalized adult patients with leukemia. Clin. Infect. Dis. 21:376-379.
230. Wilkinson, T. M., G. C. Donaldson, S. L. Johnston, P. J. Openshaw, and J. A. Wedzicha. 2006. Respiratory syncytial virus, airway inflammation, and FEV1 decline in patients with chronic obstructive pulmonary disease. Am. J. Respir. Crit. Care Med. 173:871-876.
231. Williams, J. V., P. A. Harris, S. J. Tollefson, L. L. Halburnt-Rush, J. M. Pingsterhaus, K. M. Edwards, P. F. Wright, and J. E. Crowe, Jr. 2004. Human metapneumovirus and lower respiratory tract disease in otherwise healthy infants and children. N. Engl. J. Med. 350:443-450.
232. Wilson, S. Z., V. Knight, P. R. Wyde, S. Drake, and R. B. Couch. 1980. Amantadine and ribavirin aerosol treatment of influenza A and B infection in mice. Antimicrob. Agents Chemother. 17:642-648.
233. Wong, W. M., J. C. Ho, G. C. Ooi, T. Mok, J. Chan, I. F. Hung, W. Ng, Y. M. Lam, W. O. Tam, B. C. Wong, P. C. Wong, P. L. Ho, C. L. Lai, W. K. Lam, S. K. Lam, and K. W. Tsang. 2003. Temporal patterns of hepatic dysfunction and disease severity in patients with SARS. JAMA 290:2663-2665.
234. Wright, J. J., and G. O'Driscoll. 2005. Treatment of parainfluenza virus 3 pneumonia in a cardiac transplant recipient with intravenous ribavirin and methylprednisolone. J. Heart Lung Transplant. 24:343-346.
235. Wu, C. J., J. T. Jan, C. M. Chen, H. P. Hsieh, D. R. Hwang, H. W. Liu, C. Y. Liu, H. W. Huang, S. C. Chen, C. F. Hong, R. K. Lin, Y. S. Chao, and J. T. Hsu. 2004. Inhibition of severe acute respiratory syndrome coronavirus replication by niclosamide. Antimicrob. Agents Chemother. 48:2693-2696.
236. Wu, H., D. S. Pfarr, S. Johnson, Y. A. Brewah, R. M. Woods, N. K. Patel, W. I. White, J. F. Young, and P. A. Kiener. 2007. Development of motavizumab, an ultra-potent antibody for the prevention of respiratory syncytial virus infection in the upper and lower respiratory tract. J. Mol. Biol. 368:652-665.
237. Wyde, P. R., S. N. Chetty, A. M. Jewell, G. Boivin, and P. A. Piedra. 2003. Comparison of the inhibition of human metapneumovirus and respiratory syncytial virus by ribavirin and immune serum globulin in vitro. Antiviral Res. 60:51-59.
238. Wyde, P. R., S. Z. Wilson, B. E. Gilbert, and R. H. Smith. 1986. Protection of mice from lethal influenza virus infection with high dose-short duration ribavirin aerosol. Antimicrob. Agents Chemother. 30:942-944.
239. Yamamoto, N., R. Yang, Y. Yoshinaka, S. Amari, T. Nakano, J. Cinatl, H. Rabenau, H. W. Doerr, G. Hunsmann, A. Otaka, H. Tamamura, N. Fujii, and N. Yamamoto. 2004. HIV protease inhibitor nelfinavir inhibits replication of SARS-associated coronavirus. Biochem. Biophys. Res. Commun. 318:719-725.
240. Yang, H., M. Yang, Y. Ding, Y. Liu, Z. Lou, Z. Zhou, L. Sun, L. Mo, S. Ye, H. Pang, G. F. Gao, K. Anand, M. Bartlam, R. Hilgenfeld, and Z. Rao. 2003. The crystal structures of severe acute respiratory syndrome virus main protease and its complex with an inhibitor. Proc. Natl. Acad. Sci. USA 100:13190-13195.
241. Yusuf, U., G. A. Hale, J. Carr, Z. Gu, E. Benaim, P. Woodard, K. A. Kasow, E. M. Horwitz, W. Leung, D. K. Srivastava, R. Handgretinger, and R. T. Hayden. 2006. Cidofovir for the treatment of adenoviral infection in pediatric hematopoietic stem cell transplant patients. Transplantation 81:1398-1404.
242. Zambon, M. C., J. D. Stockton, J. P. Clewley, and D. M. Fleming. 2001. Contribution of influenza and respiratory syncytial virus to community cases of influenza-like illness: an observational study. Lancet 358:1410-1416.
243. Zhang, Y., T. Li, L. Fu, C. Yu, Y. Li, X. Xu, Y. Wang, H. Ning, S. Zhang, W. Chen, L. A. Babiuk, and Z. Chang. 2004. Silencing SARS-CoV Spike protein expression in cultured cells by RNA interference. FEBS Lett. 560:141-146.
244. Zhao, Z., F. Zhang, M. Xu, K. Huang, W. Zhong, W. Cai, Z. Yin, S. Huang, Z. Deng, M. Wei, J. Xiong, and P. M. Hawkey. 2003. Description and clinical treatment of an early outbreak of severe acute respiratory syndrome (SARS) in Guangzhou, PR China. J. Med. Microbiol. 52:715-720.